Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 21;6(3):e17861.
doi: 10.1371/journal.pone.0017861.

Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads

Mashudu Madzivhandila  1 , Peter V Adrian, Clare L Cutland, Locadiah Kuwanda, Stephanie J Schrag, Shabir A Madhi
Affiliations

Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads

Mashudu Madzivhandila et al. PLoS One. .

Abstract

Background: Serotype-specific polysaccharide based group B streptococcus (GBS) vaccines are being developed. An understanding of the serotype epidemiology associated with maternal colonization and invasive disease in infants is necessary to determine the potential coverage of serotype-specific GBS vaccines.

Methods: Colonizing GBS isolates were identified by vaginal swabbing of mothers during active labor and from skin of their newborns post-delivery. Invasive GBS isolates from infants were identified through laboratory-based surveillance. GBS serotyping was done by latex agglutination. Serologically non-typeable isolates were typed by a serotype-specific PCR method. The invasive potential of GBS serotypes associated with sepsis within seven days of birth was evaluated in association to maternal colonizing serotypes.

Results: GBS was identified in 289 (52.4%) newborns born to 551 women with GBS-vaginal colonization and from 113 (5.6%) newborns born to 2,010 mothers in whom GBS was not cultured from vaginal swabs. The serotype distribution among vaginal-colonizing isolates was as follows: III (37.3%), Ia (30.1%), and II (11.3%), V (10.2%), Ib (6.7%) and IV (3.7%). There were no significant differences in serotype distribution between vaginal and newborn colonizing isolates (P = 0.77). Serotype distribution of invasive GBS isolates were significantly different to that of colonizing isolates (P<0.0001). Serotype III was the most common invasive serotype in newborns less than 7 days (57.7%) and in infants 7 to 90 days of age (84.3%; P<0.001). Relative to serotype III, other serotypes showed reduced invasive potential: Ia (0.49; 95%CI 0.31-0.77), II (0.30; 95%CI 0.13-0.67) and V (0.38; 95%CI 0.17-0.83).

Conclusion: In South Africa, an anti-GBS vaccine including serotypes Ia, Ib and III has the potential of preventing 74.1%, 85.4% and 98.2% of GBS associated with maternal vaginal-colonization, invasive disease in neonates less than 7 days and invasive disease in infants between 7-90 days of age, respectively.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: S.A.M. is currently receiving research-grant support from Novartis in relation to GBS. All other authors declare that no competing interests exist.

References

    1. Behrman RE. The new challenge in neonatal infections. Fetal and Neonatal Medicine. 1973;82:703–706. - PubMed
    1. Lancefield RC. Serological differentiation of specific types of bovine haemolytic streptococci (Group B). J Exp Med. 1934;59:458. - PMC - PubMed
    1. CDC Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC Morb Mortal Recomm Rep. 2002;51:1–22. - PubMed
    1. Beal S, Dancer S. Antenatal prevention of neonatal group B streptococcal infection. Gynaecological and Perinatal Practice. 2006;6:218–225.
    1. Eren A, Kucukercan M, Oguzoglu N, Unal N, Karateke A. The carriage of group B streptococal in Turkish pregnant women and its transmission rate in newborns and serotype distribution. The Turkish Journal of Pediatrics. 2005;13:28–33. - PubMed

Publication types